These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31602457)

  • 1. Simple Laboratory Test Utilization Interventions to Reduce Inappropriate Specialty Coagulation Testing.
    Huang H; Cunningham AM; Harrington AM
    Am J Clin Pathol; 2020 Jan; 153(2):181-189. PubMed ID: 31602457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a highly specific functional test for the detection of factor V Leiden.
    Quenhenberger P; Handler S; Mannhalter C; Pabinger-Fasching I; Speiser W
    Int J Clin Lab Res; 2000; 30(3):113-7. PubMed ID: 11196068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing the electronic request form proves to be an effective tool for optimizing laboratory test utilization in the emergency department.
    Lapić I; Juroš GF; Rako I; Rogić D
    Int J Med Inform; 2017 Jun; 102():29-34. PubMed ID: 28495346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance.
    van Oerle R; van Pampus L; Tans G; Rosing J; Hamulyák K
    Am J Clin Pathol; 1997 May; 107(5):521-6. PubMed ID: 9128263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative one-stage assays for factors V and X.
    Babson AL; Flanagan ML
    Am J Clin Pathol; 1975 Dec; 64(6):817-9. PubMed ID: 1202939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a Multifaceted Intervention With Ordering of Unnecessary Laboratory Tests Among Caregivers in Internal Medicine Departments.
    Bindraban RS; van Beneden M; Kramer MHH; van Solinge WW; van de Ven PM; Naaktgeboren CA; Al-Dulaimy M; van der Wekken LC; Bandt YC; Stam F; Neppelenbroek SIM; Griffioen-Keijzer A; Castelijn DAR; Wevers BA; Boerman AW; van Wijnen M; Ten Berg MJ; Nanayakkara PWB
    JAMA Netw Open; 2019 Jul; 2(7):e197577. PubMed ID: 31339544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of peer management on test-ordering behavior.
    Neilson EG; Johnson KB; Rosenbloom ST; Dupont WD; Talbert D; Giuse DA; Kaiser A; Miller RA;
    Ann Intern Med; 2004 Aug; 141(3):196-204. PubMed ID: 15289216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of fibrinogen split products on the activity of blood coagulation factors II, V, VII, VIII and X in the plasm].
    Schimpf K; Barth P; Wüstemann AM
    Klin Wochenschr; 1969 Apr; 47(7):391-3. PubMed ID: 5383398
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnitude of Potentially Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting.
    Mou E; Kwang H; Hom J; Shieh L; Kumar A; Richman I; Berube C
    J Hosp Med; 2017 Sep; 12(9):735-738. PubMed ID: 28914278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved test to identify aPC-resistant factor V-Leiden.
    Preda L; Erba N; Figini S; Carniti GC; Rossi E
    Thromb Res; 1997 Jun; 86(6):461-8. PubMed ID: 9219326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory methods for the estimation of plasma clotting factors. Phase 2].
    Kagami M
    Rinsho Byori; 1969; 16():Suppl 16:85-92. PubMed ID: 5391589
    [No Abstract]   [Full Text] [Related]  

  • 12. Clustered interventions to reduce inappropriate duplicate laboratory tests in an Irish tertiary hospital.
    Brady H; Piggott L; Dunne SS; O'Connell NH; Dunne CP
    Clin Biochem; 2018 Feb; 52():26-32. PubMed ID: 29056494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
    Reuner KH; Litfin F; Patscheke H
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit factor V: different effects of thrombin and venom, a source of error in assay.
    Rapaport SI; Hjort PF; Patch MJ
    Am J Physiol; 1966 Dec; 211(6):1477-85. PubMed ID: 5956566
    [No Abstract]   [Full Text] [Related]  

  • 15. Regional quality control of coagulation assay procedures (normotest, simplastin-a and thrombotest).
    Kahan J
    Thromb Diath Haemorrh; 1974 Sep; 32(1):79-89. PubMed ID: 4454048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perils in the thrombophilia workup: Frequency and circumstances of erroneously ordered factor V activity tests for thrombophilia.
    Houghton DE; Sud S; Moll S; Rollins-Raval MA
    Vasc Med; 2017 Dec; 22(6):527-528. PubMed ID: 28965480
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of Phenotypic Activated Protein C Resistance Testing With a Genetic Assay for Factor V Leiden.
    Murphy CH; Sabath DE
    Am J Clin Pathol; 2019 Feb; 151(3):302-305. PubMed ID: 30423028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex testing for Factor II and Factor V mutations in thrombophilia: technical verification and clinical validation of the cobas® Factor II and Factor V test.
    Longshore JW; DeMartin K; Yu K; Das P; Zhang G; Rehage TT; Jethwaney D; Karwowska S
    J Thromb Thrombolysis; 2019 Jan; 47(1):87-95. PubMed ID: 30284176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coagulation tests from capillary blood. Determination of thromboplastin time, thrombin time, fibrinogen, factor II (prothrombin), factor V (accelerin) and factor X (Stuart-Prower factor) from capillary blood].
    Muntean W
    Z Kinderheilkd; 1975; 118(4):337-46. PubMed ID: 1130122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing utilization of new diagnostic tests.
    Lewandrowski K
    Clin Leadersh Manag Rev; 2003; 17(6):318-24. PubMed ID: 14692073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.